NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation.
Rongrong WuArya Mariam RoyYoshihisa TokumaruShipra GandhiMariko AsaokaMasanori OshiLi YanTakashi IshikawaKazuaki TakabePublished in: Cancers (2022)
expression in breast cancer is associated with tumor dormancy traits, and it is predominantly expressed in CAFs in the tumor microenvironment.